Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: a systematic literature review

Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial(STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study)

(2015) Bruno Fautrel et al.   ANNALS OF THE RHEUMATIC DISEASES

A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study

(2014) Jakub Závada et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

(2013) R Landewé et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-Term Efficacy of Adalimumab After Drug Withdrawal and Retreatment in Patients With Active Non-Radiographically Evident Axial Spondyloarthritis Who Experience a Flare

(2013) H. Haibel et al.   ARTHRITIS AND RHEUMATISM

Clinical and economic impact of the use of etanercept 25 mg once weekly in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis patients

(2013) Joaquín Borrás-Blasco et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Infliximab Dose Reduction Sustains the Clinical Treatment Effect in Active HLAB27 Positive Ankylosing Spondylitis: A Two-Year Pilot Study

(2013) Boel Mörck et al.   MEDIATORS OF INFLAMMATION

Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial

(2012) In-Ho Song et al.   ANNALS OF THE RHEUMATIC DISEASES

Dosage Adjustment of Anti-Tumor Necrosis Factor-α Inhibitor in Ankylosing Spondylitis Is Effective in Maintaining Remission in Clinical Practice

(2012) JULIEN PACCOU et al.   JOURNAL OF RHEUMATOLOGY

Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept

(2012) Xiaohu Deng et al.   RHEUMATOLOGY INTERNATIONAL

Low doses of etanercept can be effective in ankylosing spondylitis patients who achieve remission of the disease

(2011) Victoria Navarro-Compán et al.   CLINICAL RHEUMATOLOGY

Extended dosing of etanercept 25 mg can be effective in patients with ankylosing spondylitis: a retrospective analysis

(2010) Jaejoon Lee et al.   CLINICAL RHEUMATOLOGY

Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials

(2008) T Bongartz et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

(2008) Robert D. Inman et al.   ARTHRITIS AND RHEUMATISM